Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

02.03.2018 | editorial

In need of special care: adolescent and young adult patients with cancer

verfasst von: Assoc. Prof. Michael N. Dworzak, M.D., Ph.D.

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Auszug

The adolescent and young adult (AYA) period is generally defined as the range between 15–39 years of age [1]. Awareness of the special medical needs of this age group has come into focus as represented by the exceptional increase of publications in the field, ranging from six in 1997 to 59 in 2007, and to 269 in 2017 (MEDLINE®, 07 February 2018). AYA patients suffer from a spectrum of cancers that are either similar to ‘paediatric’ cancers (such as acute lymphoblastic leukaemia [ALL], sarcoma, and brain tumours) or ‘adult’ tumours (such as breast cancer and melanoma) or are cancers quite unique to their age group (such as testicular cancer and bone tumours; [1]). In addition, the peak in incidence of certain cancers like Hodgkin lymphoma or germ cell tumours falls into the AYA period [2]. …
Vorheriger Artikel Uro-oncology 2018: new horizons, new treatment options, improved patient outcomes
Nächster Artikel memo—publisher’s report 2017
Literatur
1.
Sender L, Zabokrtsky KB. Adolescent and young adult patients with cancer: a milieu of unique features. Nat Rev Clin Oncol. 2015;12:465–80.CrossRefPubMed
2.
Desandes E, Stark DP. Epidemiology of adolescents and young adults with cancer in Europe. Prog Tumor Res. 2016;43:1–15.CrossRefPubMed
3.
Place AE, Frederick NN, Sallan SE. Therapeutic approaches to haematological malignancies in adolescents and young adults. Br J Haematol. 2014;164(1):3–14.CrossRefPubMed
4.
Davis LE, Janeway KA, Weiss AR, Chen YE, Scharschmidt TJ, Krailo M, Glade Bender JL, Kopp LM, Patel SR, Schwartz GK, Horvath LE, Hawkins DS, Chuk MK, Reinke DK, Gorlick RG, Randall RL. Clinical trial enrollment of adolescents and young adults with sarcoma. Cancer. 2017;123(18):3434–40.CrossRefPubMedPubMedCentral
5.
Rotz SJ, Nagarajan R, Sorger JI, Pressey JG. Challenges in the treatment of sarcomas of adolescents and young adults. J Adolesc Young Adult Oncol. 2017;6(3):406–13.PubMed
6.
Ferrari A, Barr RD. International evolution in AYA oncology: current status and future expectations. Pediatr Blood Cancer. 2017;64(9):e26528.CrossRef
7.
8.
Lang MJ, David V, Giese-Davis J. The age conundrum: a scoping review of younger age or adolescent and young adult as a risk factor for clinical distress, depression, or anxiety in cancer. J Adolesc Young Adult Oncol. 2015;4(4):157–73.CrossRefPubMedPubMedCentral
9.
Barnett M, McDonnell G, DeRosa A, Schuler T, Philip E, Peterson L, Touza K, Jhanwar S, Atkinson TM, Ford JS. Psychosocial outcomes and interventions among cancer survivors diagnosed during adolescence and young adulthood: a systematic review. J Cancer Surviv. 2016;10(5):814–31.CrossRefPubMedPubMedCentral
10.
Bardi E, Kager L. Novel guidelines on surveillance for breast cancer, cardiomyopathy, male gonadotoxicity, and premature ovarian insufficiency from the PanCare and International Guideline Harmonization Group on long-term follow-up after cancer in childhood. Memo. 2018;11. https://​doi.​org/​10.​1007/​s12254-018-0387-z.
11.
Murphy D, Orgel E, Termuhlen A, Shannon S, Warren K, Quinn GP. Why healthcare providers should focus on the fertility of AYA cancer survivors: it’s not too late! Front Oncol. 2013;7(3):248.
Metadaten
Titel
In need of special care: adolescent and young adult patients with cancer
verfasst von
Assoc. Prof. Michael N. Dworzak, M.D., Ph.D.
Publikationsdatum
02.03.2018
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 1/2018
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-018-0395-z

Weitere Artikel der Ausgabe 1/2018

ESMO 2017—my personal highlights

  • Open Access
  • comment

Cell free nucleic acids as diagnostic and prognostic marker in leukemia

  • review

Local therapy of stage IV renal cell cancer: a case report

  • case report

Uro-oncology 2018: new horizons, new treatments, better outcomes

Revival of anti-angiogenic therapies in cancer

PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients

  • Open Access
  • short review